Basic Sciencelow evidence
IRF2BP2-FOSL2 interaction regulates SOX9-mediated cartilage regeneration in osteoarthritis models.
The Journal of clinical investigation·October 15, 2026·PMID 42878073
Why it mattersOsteoarthritis lacks effective disease-modifying therapies. This work uncovers a novel regulatory axis—IRF2BP2/FOSL2/SOX9—that controls chondrocyte phenotype and cartilage repair. Targeting this pathway with intra-articular agents may offer a new therapeutic strategy for OA and cartilage regeneration.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled